| Title | COG-AALL0932 Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-lineage Lymphoblastic Lymphoma (B-LLy) |
|---|---|
| Full Title | COG-AALL0932 Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-lineage Lymphoblastic Lymphoma (B-LLy) |
| Disease/Condition | Pediatric Hematology/Oncology |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Lisa Figueiredo |
| Contact Name | Joyce Brown |
| Contact Email | joycbrow@montefiore.org |
| Protocol Number | IRB# 2015-4850 |
| Inclusion/Notes | This information was obtained from ClinicalTrials.gov. |
| Status | Enrolling |
| Adult Clinical Trial | No |
| Pediatric Clinical Trial | No |
| Adult, Pediatric, Both | Adult |